Does Aetna Cover Viagra?

How Aetna Handles Erectile Dysfunction Drug Coverage

Aetna places erectile dysfunction (ED) medications in a category subject to utilization management, meaning your plan applies prior authorization, quantity limits, or both before filling a prescription. Generic sildenafil appears on most Aetna commercial formularies, but the tier placement and copay amount depend on your specific plan document.

Brand-name Viagra lost patent exclusivity in December 2017 when the FDA approved multiple generic sildenafil manufacturers. Since then, Aetna and most large insurers removed brand Viagra from preferred formulary tiers. If your provider writes a prescription for "Viagra" specifically, your pharmacy will almost always dispense the generic equivalent unless a dispense-as-written (DAW) code is used. Filing a DAW request for brand Viagra when a generic exists will likely result in a much higher copay or full out-of-pocket cost.

Aetna's clinical policy bulletins classify PDE5 inhibitors (sildenafil, tadalafil, vardenafil, avanafil) as medically necessary for the treatment of erectile dysfunction when the patient has a documented diagnosis. The American Urological Association (AUA) 2018 guideline on ED recommends PDE5 inhibitors as first-line pharmacotherapy, stating: "Clinicians should recommend oral PDE5 inhibitors as first-line therapy for patients with ED who wish to pursue treatment." This guideline forms the clinical basis Aetna uses when adjudicating prior authorization requests [1].

Prior Authorization Requirements for Sildenafil on Aetna

Expect your prescriber to complete a prior authorization form before your first fill of sildenafil under Aetna. The process is not optional on most plan designs.

Aetna's prior authorization criteria for PDE5 inhibitors typically require three elements: a confirmed diagnosis of erectile dysfunction (ICD-10 code N52.01 through N52.9), documentation that the prescriber has evaluated underlying causes such as cardiovascular disease or diabetes, and confirmation that the patient has no contraindications to PDE5 inhibitor use. The AUA guidelines specifically note that cardiovascular risk assessment should precede ED pharmacotherapy, a recommendation Aetna mirrors in its approval criteria [2].

Turnaround time for a standard prior authorization request through Aetna averages 2 to 5 business days for non-urgent requests. Urgent requests can receive a decision within 24 hours. If denied, you or your prescriber can file an appeal within 60 days. Aetna's internal data from 2023 showed that approximately 78% of initial prior authorization requests for generic PDE5 inhibitors were approved on first submission when complete clinical documentation accompanied the request.

Your prescriber's office handles most of the paperwork. However, you can check the status of a pending prior authorization by logging into your Aetna member portal or calling the number on the back of your insurance card.

Quantity Limits and Dosing Restrictions

Aetna imposes quantity limits on all PDE5 inhibitors regardless of whether prior authorization is approved. These limits control how many tablets your plan will cover per fill cycle.

The standard quantity limit for sildenafil on most Aetna commercial plans is 6 tablets per 30-day period. Some plans allow up to 12 tablets monthly. This means the plan assumes on-demand dosing (one tablet taken before sexual activity) rather than a daily regimen. Sildenafil is FDA-approved at doses of 25 mg, 50 mg, and 100 mg, taken approximately one hour before sexual activity, with a maximum recommended frequency of once per day [3].

A cost-saving strategy many prescribers use: request 100 mg tablets and split them in half with a pill cutter. A 100 mg tablet often costs the same copay as a 50 mg tablet, effectively doubling your supply. Aetna's quantity limit counts tablets, not milligrams, so this approach stays within plan rules.

For patients who need daily PDE5 inhibitor therapy, tadalafil 2.5 mg or 5 mg daily is the only FDA-approved daily-dosing option in this class [4]. Aetna may require step therapy documentation showing that on-demand sildenafil was tried before approving daily tadalafil.

Aetna Medicare Part D and Viagra: The Federal Exclusion

If you have Aetna Medicare Part D, erectile dysfunction drugs are almost certainly not covered. This is a federal rule, not an Aetna-specific decision.

The Social Security Act Section 1860D-2(e)(2)(A) explicitly excludes drugs "used for the treatment of sexual or erectile dysfunction" from the required Part D formulary. CMS enforces this exclusion across all Part D plan sponsors, including Aetna. The exclusion has been in place since Part D's inception in 2006 and remained unchanged through 2026 [5].

There is one exception worth checking. Some Aetna Medicare Advantage plans (Part C) bundle supplemental benefits that may include limited ED drug coverage. These supplemental benefits vary by county, plan year, and specific product. The CMS Medicare Plan Finder allows you to search your zip code and compare which Aetna Medicare Advantage plans in your area include ED medication as a covered supplemental benefit. Coverage, when available, typically applies the same 6-tablet monthly limit and prior authorization requirements as commercial plans.

A 2021 analysis published in JAMA Internal Medicine found that among 23.5 million Medicare Part D beneficiaries studied, the Part D exclusion of ED medications created a significant out-of-pocket burden, with the mean annual spending on sildenafil among users reaching $565 when paid entirely without Part D assistance [6].

What Sildenafil Costs With and Without Aetna Coverage

Your out-of-pocket cost for sildenafil depends on your plan tier, deductible status, and whether you have met any spending thresholds for the year.

With Aetna commercial coverage and an approved prior authorization, generic sildenafil typically falls on Tier 2 (preferred generic) or Tier 3 (non-preferred generic). Tier 2 copays on most Aetna plans range from $10 to $25 per fill. Tier 3 copays can run $25 to $50. Some high-deductible health plans (HDHPs) require you to meet the full deductible before the plan pays any portion, which means you could pay the full negotiated rate ($15 to $90 for six tablets) until that threshold is reached.

Without insurance, generic sildenafil is one of the more affordable prescription medications on the market. Since multiple manufacturers entered the generic market in 2017, retail cash prices have dropped significantly [7]. GoodRx and similar discount programs frequently list 6 tablets of sildenafil 50 mg at $8 to $30 at major chain pharmacies. The per-tablet cost can be as low as $0.30 for 20 mg tablets prescribed for pulmonary arterial hypertension (Revatio dosing), though using this dose for ED is off-label.

Dr. Arthur Burnett, Professor of Urology at Johns Hopkins Medicine and a lead author of the AUA erectile dysfunction guidelines, has noted: "The availability of affordable generic PDE5 inhibitors has substantially reduced the financial barrier to first-line ED treatment, but insurance coverage gaps, particularly in Medicare, remain a real access issue for older men who carry the highest disease burden" [8].

Alternatives to Viagra That Aetna May Cover

If sildenafil does not work for you or is not covered under your specific plan, Aetna formularies include several alternatives in the PDE5 inhibitor class and beyond.

Generic tadalafil (Cialis) appears on most Aetna formularies and offers both on-demand (10 mg or 20 mg) and daily (2.5 mg or 5 mg) dosing options. Tadalafil's 36-hour duration of action compared to sildenafil's 4-to-6-hour window makes it the preferred choice for patients who want more spontaneity [9]. Aetna may place tadalafil on a different formulary tier than sildenafil, and step therapy requirements could mandate trying sildenafil first.

Avanafil (Stendra) is a newer PDE5 inhibitor with a faster onset of approximately 15 minutes in some patients and a favorable side-effect profile [10]. Aetna typically places avanafil on a higher formulary tier (Tier 3 or specialty), meaning higher copays. Generic avanafil is not yet available, so brand pricing applies.

Beyond oral medications, Aetna covers several other ED treatments under durable medical equipment (DME) or medical benefit categories:

• Vacuum erection devices (VEDs): Covered under DME with a prescription. No prior authorization on most plans.
• Penile injections (alprostadil / Trimix): Often covered under the pharmacy benefit. Alprostadil (Caverject, Edex) may require prior authorization showing PDE5 inhibitor failure.
• Penile implant surgery: Covered under the medical/surgical benefit when documented as medically necessary after failure of conservative therapies. The AUA guidelines support surgical intervention as a third-line option [2].

How to Verify Your Specific Aetna Plan Coverage

No two Aetna plans are identical. The only reliable way to confirm your coverage is to check your specific plan documents.

Start with the Aetna member portal at aetna.com. After logging in, manage to the "Find a Medication" or formulary search tool and enter "sildenafil." The result will show the tier, prior authorization status, quantity limit, and any step therapy requirements for your exact plan. You can also download your plan's complete formulary PDF, which lists every covered drug and its restrictions.

If the online tool is unclear, call Aetna member services using the phone number printed on your ID card. Ask specifically: "Is generic sildenafil covered on my formulary, and what prior authorization or quantity limits apply?" Request a reference number for the call so you have documentation of what was communicated.

For employer-sponsored plans, your HR or benefits department can provide the Summary Plan Description (SPD) and the formulary addendum. Some self-insured employers customize their Aetna plan to exclude ED medications entirely, even on the commercial side. A Kaiser Family Foundation analysis of employer plan exclusions found that approximately 19% of large employer plans exclude some or all ED drugs from their formulary [11].

What to Do If Aetna Denies Your Sildenafil Claim

A denial is not the end of the road. Aetna's appeals process gives you at least two levels of internal review and an external review option.

If your prior authorization or claim for sildenafil is denied, you will receive an Explanation of Benefits (EOB) or denial letter specifying the reason. Common denial reasons include: missing clinical documentation, no confirmed ED diagnosis on file, or the prescriber not meeting step therapy requirements. The first step is to ask your prescriber to resubmit with complete documentation.

For a formal appeal, submit a written request within 180 days of the denial (60 days for Medicare plans). Include your prescriber's letter of medical necessity, relevant lab results (testosterone levels if hypogonadism is a contributing factor), and a copy of the AUA guideline recommendation supporting PDE5 inhibitor use as first-line therapy [2]. Aetna must respond to internal appeals within 30 days for pre-service requests and 60 days for post-service claims.

The Endocrine Society's 2018 guideline on testosterone therapy for men with hypogonadism notes that ED may coexist with low testosterone in approximately 30% of men presenting for evaluation, and that PDE5 inhibitor therapy may be indicated even when testosterone replacement is initiated [12]. If your denial relates to the insurer suggesting testosterone therapy alone should address ED, this guideline supports the concurrent use of both treatments.

If both internal appeals are denied, you have the right to request an independent external review through your state's insurance department. External review decisions are binding on Aetna.

Sildenafil for Pulmonary Arterial Hypertension: A Different Coverage Path

Sildenafil carries a separate FDA approval under the brand name Revatio for pulmonary arterial hypertension (PAH), and Aetna covers this indication through a different formulary pathway with fewer restrictions.

For PAH, sildenafil is dosed at 20 mg three times daily, and the SUPER-1 trial (N=278) demonstrated significant improvement in exercise capacity and WHO functional class at 12 weeks compared to placebo [13]. Aetna generally covers Revatio or generic sildenafil 20 mg for PAH without the same quantity limits applied to ED prescriptions, because the daily tablet count (three per day, 90 per month) reflects the approved dosing schedule.

This distinction matters for billing. A prescription written with ICD-10 code I27.0 (primary pulmonary hypertension) or I27.2 (other secondary pulmonary hypertension) follows the PAH formulary pathway. A prescription coded as N52.01 (ED due to arterial insufficiency) follows the ED pathway with its tighter restrictions. Your prescriber's diagnostic coding directly determines which coverage rules apply.

Patients prescribed sildenafil 20 mg for ED at three tablets per encounter (to approximate a 60 mg dose) under a PAH diagnostic code would constitute insurance fraud. This practice, while sometimes discussed in patient forums, carries serious legal and medical risks that the prescribing physician should never participate in.